QualityStocksNewsBreaks Archives - Page 1028 of 1386

TuesdayAug 27, 2019 10:08 am

QualityStocksNewsBreaks – TransCanna Holdings Inc.’s (CSE: TCAN) (FSE: TH8) Warrants Commence Trading on the CSE

TransCanna Holdings (CSE: TCAN) (FSE: TH8) this morning announced that 4,207,083 common share purchase warrants began trading on the Canadian Securities Exchange (“CSE”) under the symbol ‘TCAN.WT’ as the market opened today. The warrants, each of which entitle the holder to purchase one common share of the company, were issued in accordance with a private placement financing that closed in April 2019. The warrants will expire on April 4, 2022. To view the full press release, visit http://ibn.fm/Vqk4t About TransCanna Holdings Inc. TransCanna Holdings is a Canadian-based company providing branding, transportation and distribution services, through its wholly owned California subsidiaries,…

TuesdayAug 27, 2019 9:55 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Receives DehydraTECH Patent for Pharmaceutical Applications of Cannabinoids to Treat Certain Conditions

Biotechnology company and global drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today announced its receipt of a new patent granted in Australia: #2016367037 / Grant Date August 15, 2019 - “Stable ready-to-drink beverage compositions comprising lipophilic active agents.” According to the update, this increases Lexaria’s portfolio to 16 awarded patents protecting its DehydraTECH(TM) drug delivery platform, with eight in the USA and eight in Australia. The new Australian patent, together with Australian Patent #2016367036 announced on August 15, 2019, are the first granted in Lexaria’s second and third patent families that differ from the company’s original…

TuesdayAug 27, 2019 9:24 am

QualityStocksNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Posts Q1 Fiscal 2020 Financial Results, Provides Corporate Update

Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) this morning reported financial results for the first quarter ended June 30, 2019. Among other highlights, the company reported an operating income of $2.7 million for the quarter which it primarily attributes to royalty, interest and lease income. Canopy Rivers took advantage of new invest opportunities during the quarter, providing $18.8 million to new investments in Biolumic, Zeakal and High Beauty in addition to contributing a total of $6 million to existing investees Greenhouse Juice Company and Agripharm. “In Q1 2020, we made several exciting investments in plant sciences and cannabis brands, two areas…

MondayAug 26, 2019 3:02 pm

QualityStocksNewsBreaks – Marijuana Company of America Inc. (MCOA) Launches Premium Cannabis Delivery Service

Marijuana Company of America (OTCQB: MCOA), an innovative hemp and cannabis corporation, recently hosted a virtual launch party of its premium cannabis delivery service, VivaBuds. “VivaBuds will offer our customers low-cost premium cannabis, fast delivery times and quality customer service,” MCOA CEO Don Steinberg stated in the news release (http://ibn.fm/kRMzL). An article discussing the company reads, “The establishment of a joint venture with Natural Plant Extract of California (‘NPE’), along with a 20% ownership stake in the company, led to the creation of Viva Buds Inc., a unique, Los Angeles, California-based cannabis delivery service. MCOA’s commitment to the joint venture…

MondayAug 26, 2019 2:56 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures Agreement with Prominent Biotherapeutics Firm

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life-sciences and other industries, recently executed a contract services agreement with a well-known biotherapeutics firm. An article discussing the company reads, “Under the terms of the agreement, the firm will utilize PBIO’s proprietary BaroFold(TM) technology platform to enhance the process manufacturing of one of its candidate protein drugs (http://ibn.fm/aidN2). . . . PBIO’s BaroFold technology platform offers a unique and cost-effective way to address the complex and often-challenging process of manufacturing the recombinant proteins that are required in the development…

MondayAug 26, 2019 11:55 am

QualityStocksNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Acquires 824-Acre Potrero Ranch Hemp Cultivation Property

Innovative, full-scope, science-driven, premium hemp cultivation and branding enterprise Green Hygienics Holdings (OTCQB: GRYN) today announced completion of its previously disclosed acquisition of the 824-acre Potrero Ranch Property near San Diego, California. According to the update, the company will utilize the land and buildings for industrial hemp for CBD cultivation. “We have been working at the property under a lease agreement for the last two months purchasing equipment and preparing to begin cultivation immediately,” GRYN CEO Ron Loudoun stated in the news release. “The combination of the greenhouse space and acreage will create the capability to produce significant revenues for…

MondayAug 26, 2019 11:24 am

QualityStocksNewsBreaks – Youngevity International Inc.’s (NASDAQ: YGYI) Khrysos Industries Leases State- of-the-Art, Florida Based Hemp Processing and Manufacturing Facility

Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments, through its wholly owned subsidiary, Khrysos Industries, Inc., today announced that it has leased 82,000 square feet in Orlando, Florida to house its facility for post processing hemp derived products and finished goods manufacturing. The state-of-the-art facility features a 46,200 square foot production area and is the former home of Nephron Pharmaceuticals GMP Certified sterile manufacturing operations. "We believe this facility provides us the opportunity to accelerate our post processing and manufacturing capabilities by approximately two years in terms of production output. The amenities and…

MondayAug 26, 2019 10:41 am

QualityStocksNewsBreaks – Canopy Rivers Inc.’s (TSX.V: RIV) (OTC: CNPOF) Headset Launches Cannabis Market Intelligence Tool in Canada

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced that its portfolio company, Headset, Inc., has launched its competitive cannabis market intelligence tool in Canada. Headset Insights is already trusted by hundreds of operators in numerous U.S. markets and provides users with real-time market data to help uncover strategic opportunities, monitor consumer trends and behaviors, and keep tabs on competitors. "This announcement from Headset is a testament to the company's rapid growth since being backed by RIV and joining our ecosystem in January 2019," Canopy Rivers President and CEO Narbe Alexandrian said in the news release. "We believe that Headset…

MondayAug 26, 2019 9:59 am

QualityStocksNewsBreaks – SinglePoint, Inc.’s (SING) Direct Solar Enters Partnership with Inc 500 “A Fastest Growing Company” – My Home Group Real Estate, LLC.

Technology and investment company SinglePoint (OTCQB: SING) through its subsidiary, Direct Solar, this morning announced entry into a partnership with My Home Group Real Estate, LLC., named “A fastest growing company” by Inc 500 five years in a row, and Arizona’s number one and the nation’s second fastest growing residential real estate brokerage. Under the new partnership, My Home Group agents will be able to provide homeowners searching for cleaner alternative fuel systems or alternatives to reduce grid reliance or the burden of increasingly higher utility bills with eco-conscious energy options. “When a My Home Group real estate professional recommends…

FridayAug 23, 2019 2:56 pm

QualityStocksNewsBreaks – INmune Bio Inc. (NASDAQ: INMB) Advances Clinical Development of INB03

INmune Bio (NASDAQ: INMB) co-founder and CEO Dr. RJ Tesi recently reported positive preliminary data from the company’s INB03 Phase I clinical trial in cancer patients during a presentation at Cambridge Healthtech Institute’s 7th Annual Immuno-Oncology Summit in Boston (http://ibn.fm/m1Iy3). An article discussing the company reads, “‘The goal of the Phase I study is to determine, in order of priority, the safety of INB03 in cancer patients, the dose of INB03 to take into the Phase II trials in cancer, and evidence of a biologic effect of INB03,’ stated Tesi, who is also INmune Bio’s chief medical officer. ‘All of…

Site Search

Company Search

Category: QualityStocksNewsBreaks